311 related articles for article (PubMed ID: 23446627)
1. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.
Fritz SA; Tiemann KM; Hogan PG; Epplin EK; Rodriguez M; Al-Zubeidi DN; Bubeck Wardenburg J; Hunstad DA
Clin Infect Dis; 2013 Jun; 56(11):1554-61. PubMed ID: 23446627
[TBL] [Abstract][Full Text] [Related]
2. High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection.
Hermos CR; Yoong P; Pier GB
Clin Infect Dis; 2010 Nov; 51(10):1138-46. PubMed ID: 20946065
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ
PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030
[TBL] [Abstract][Full Text] [Related]
4. Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin.
Brown EL; Bowden MG; Bryson RS; Hulten KG; Bordt AS; Forbes A; Kaplan SL
Clin Vaccine Immunol; 2009 Jan; 16(1):139-41. PubMed ID: 19005019
[TBL] [Abstract][Full Text] [Related]
5. Impaired T-Lymphocyte Responses During Childhood Staphylococcus aureus Infection.
Li Z; Beesetty P; Gerges G; Kleinhenz M; Moore-Clingenpeel M; Yang C; Ahmed LB; Hensley J; Steele L; Chong AS; Montgomery CP
J Infect Dis; 2022 Jan; 225(1):177-185. PubMed ID: 34145461
[TBL] [Abstract][Full Text] [Related]
6. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
[TBL] [Abstract][Full Text] [Related]
7. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
[TBL] [Abstract][Full Text] [Related]
8. Panton-Valentine Positive Staphylococcus aureus in Community-Acquired and Hospital-Acquired Pediatric Infections.
Bádue Pereira MF; Bando SY; Sasagawa SM; da Silva CB; Mimica MJ; Berezin EN
Pediatr Infect Dis J; 2019 Oct; 38(10):1068-1070. PubMed ID: 31568145
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.
Yoong P; Pier GB
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2241-6. PubMed ID: 20133867
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of SCCmec types and Panton-Valentine leukocidin in community-acquired and nosocomial Staphylococcus aureus strains: comparing skin and soft tissue infections to the other infections].
Gülmez D; Sancak B; Ercis S; Karakaya J; Hasçelik G
Mikrobiyol Bul; 2012 Jul; 46(3):341-51. PubMed ID: 22951646
[TBL] [Abstract][Full Text] [Related]
11. Panton-Valentine leukocidin associated staphylococcal disease: a cross-sectional study at a London hospital, England.
Shallcross LJ; Williams K; Hopkins S; Aldridge RW; Johnson AM; Hayward AC
Clin Microbiol Infect; 2010 Nov; 16(11):1644-8. PubMed ID: 20969671
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection.
Croze M; Dauwalder O; Dumitrescu O; Badiou C; Gillet Y; Genestier AL; Vandenesch F; Etienne J; Lina G
Clin Microbiol Infect; 2009 Feb; 15(2):144-8. PubMed ID: 19154491
[TBL] [Abstract][Full Text] [Related]
13. The levels of antibodies to Panton-Valentine leukocidin (PVL) vary with PVL prevalence along a north-to-south gradient.
Rasigade JP; Trouillet-Assant S; Breurec S; Antri K; Lina G; Bes M; Tristan A; Badiou C; Bernelin M; Fall C; Ramdani-Bouguessa N; Etienne J; Vandenesch F; Laurent F
Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):927-33. PubMed ID: 25575949
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus carrying lukS/F Panton-Valentine Leukocidin (PVL) toxin genes in hospitals of Lahore city.
Iqbal MS; Saleem Y; Ansari F; Qamar MU; Mazhar S; Hassan A; Nawaz S; Saeed S; Syed Q
J Infect Dev Ctries; 2018 Sep; 12(9):720-725. PubMed ID: 31999629
[TBL] [Abstract][Full Text] [Related]
15. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium.
Denis O; Deplano A; De Beenhouwer H; Hallin M; Huysmans G; Garrino MG; Glupczynski Y; Malaviolle X; Vergison A; Struelens MJ
J Antimicrob Chemother; 2005 Dec; 56(6):1103-6. PubMed ID: 16223937
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults.
Landrum ML; Lalani T; Niknian M; Maguire JD; Hospenthal DR; Fattom A; Taylor K; Fraser J; Wilkins K; Ellis MW; Kessler PD; Fahim RE; Tribble DR
Hum Vaccin Immunother; 2017 Apr; 13(4):791-801. PubMed ID: 28010246
[TBL] [Abstract][Full Text] [Related]
17. α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus.
Cardot-Martin E; Casalegno JS; Badiou C; Dauwalder O; Keller D; Prévost G; Rieg S; Kern WV; Cuerq C; Etienne J; Vandenesch F; Lina G; Dumitrescu O
Lett Appl Microbiol; 2015 Aug; 61(2):158-64. PubMed ID: 25963798
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme-linked immunosorbent assay and immunochromatographic tests.
Badiou C; Dumitrescu O; George N; Forbes AR; Drougka E; Chan KS; Ramdani-Bouguessa N; Meugnier H; Bes M; Vandenesch F; Etienne J; Hsu LY; Tazir M; Spiliopoulou I; Nimmo GR; Hulten KG; Lina G
J Clin Microbiol; 2010 Apr; 48(4):1384-90. PubMed ID: 20129971
[TBL] [Abstract][Full Text] [Related]
19. Panton-Valentine leukocidin is associated with exacerbated skin manifestations and inflammatory response in children with community-associated staphylococcal scarlet fever.
Lo WT; Tang CS; Chen SJ; Huang CF; Tseng MH; Wang CC
Clin Infect Dis; 2009 Oct; 49(7):e69-75. PubMed ID: 19725782
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of the presence of Panton-Valentine leukocidin and clonal relationship of community- and hospital-acquired clinical isolates of Staphylococcus aureus].
Duman Y; Tekeroğlu MS; Otlu B
Mikrobiyol Bul; 2013 Jul; 47(3):389-400. PubMed ID: 23971918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]